Clinical Trials Directory

Trials / Terminated

TerminatedNCT05018247

Early Revascularization in Stable Ischemic Heart Disease Using P.E.T. Imaging

A Prospective, Randomized Trial of Early Revascularization in Stable Ischemic Heart Disease Guided by Positron Emission Tomography of Artery Specific Integrated Comprehensive Quantitative Myocardial Perfusion

Status
Terminated
Phase
N/A
Study type
Interventional
Enrollment
14 (actual)
Sponsor
The University of Texas Health Science Center, Houston · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

To compare the impact of revascularization and Optimal Medical Treatment (OMT) on the extent of severely reduced coronary flow capacity in stable ischemic heart disease.

Detailed description

The initial Positron Emission Tomography (PET) scan will be performed as part of clinical practice. If the patient is a potential candidate for the study, the patient will be screened for inclusion and exclusion criteria. After being informed about the study potential risks, all patients giving written informed consent will be randomized into one of two groups: Urgent revascularization combined with Optimal Medical Treatment (OMT) or OMT with delayed revascularization. Following the initial PET scan, randomization and treatment, each group will undergo a second PET scan at the 3-4 month mark and a third PET scan at the one year mark. Some crossover may occur with the two groups. The OMT without urgent revascularization patients will remain in that group, if clinically stable, up to three months. At their first follow-up visit (Day 105±20), patients will be offered the option of continued medical treatment or elective revascularization consistent with informed patient preference and clinical judgement. Patients, in consultation with their physicians, may elect to undergo revascularization at any time thereafter.

Conditions

Interventions

TypeNameDescription
PROCEDURERevascularization by Coronary Artery Bypass Graft or Percutaneous Coronary InterventionUrgent revascularization via CABG or PCI combined with Optimal Medical Treatment

Timeline

Start date
2021-05-04
Primary completion
2022-05-19
Completion
2022-05-19
First posted
2021-08-24
Last updated
2023-10-18

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT05018247. Inclusion in this directory is not an endorsement.